M. S. Lawrence, P. Stojanov, P. Polak, G. V. Kryukov, K. Cibulskis et al., Mutational heterogeneity in cancer and the search for new cancerassociated genes, Nature, vol.499, pp.214-222, 2013.

Y. Godet, J. Desfrancois, V. Vignard, D. Schadendorf, A. Khammari et al., Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy, Eur J Immunol, vol.40, pp.1786-94, 2010.

N. Labarriere, A. Fortun, A. Bellec, A. Khammari, B. Dreno et al., A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma, Clin Dev Immunol, p.932318, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-01727317

S. Pinto, D. Sommermeyer, C. Michel, S. Wilde, D. Schendel et al., Misinitiation of intrathymic MART-1 transcription and biased TCR usage explain the high frequency of MART-1-specific T cells, Eur J Immunol, vol.44, pp.2811-2832, 2014.

L. Trautmann, N. Labarriere, F. Jotereau, V. Karanikas, N. Gervois et al., Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens, Eur J Immunol, vol.32, pp.3181-90, 2002.

P. Y. Dietrich, L. Gal, F. A. Dutoit, V. Pittet, M. J. Trautman et al., Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen, J Immunol, vol.170, pp.5103-5112, 2003.

M. Bobinet, V. Vignard, L. Florenceau, F. Lang, N. Labarriere et al., Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylation, PLoS ONE, vol.8, 2013.

D. Carbonnelle, V. Vignard, D. Sehedic, A. Moreau-aubry, L. Florenceau et al., The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences, PLoS ONE, vol.8, p.75233, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-01726993

M. Charpentier, M. Croyal, D. Carbonnelle, A. Fortun, L. Florenceau et al., IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens, Oncotarget, vol.7, pp.59704-59717, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01409602

S. Simon, V. Vignard, E. Varey, T. Parrot, A. Knol et al., Emergence of high-avidity melan-a-specific clonotypes as a reflection of Anti-PD-1 clinical efficacy, Cancer Res, vol.77, pp.7083-7086, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01636933

L. Kuchenbecker, M. Nienen, J. Hecht, A. U. Neumann, N. Babel et al., IMSEQ-a fast and error aware approach to immunogenetic sequence analysis, Bioinformatics, vol.31, pp.2963-71, 2015.

V. Vignard, B. Lemercier, A. Lim, M. C. Pandolfino, Y. Guilloux et al., Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells, J Immunol, vol.175, pp.4797-805, 2005.

S. Mandruzzato, E. Rossi, F. Bernardi, V. Tosello, B. Macino et al., Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient, J Immunol, vol.169, pp.4017-4041, 2002.

D. Valmori, V. Dutoit, V. Schnuriger, A. Quiquerez, M. J. Pittet et al., Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity, J Immunol, vol.168, pp.4231-240, 2002.

F. Serana, A. Sottini, L. Caimi, B. Palermo, P. G. Natali et al., Identification of a public CDR3 motif and a biased utilization of Tcell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients, J Transl Med, vol.7, p.21, 2009.

S. Wieckowski, P. Baumgaertner, P. Corthesy, V. Voelter, P. Romero et al., Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients, J Immunol, vol.183, pp.5397-406, 2009.

Y. Monod, M. Giudicelli, V. Chaume, D. Lefranc, and M. ,

V. and V. Junctions, IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor, pp.379-85, 2004.

D. K. Cole, F. Yuan, P. J. Rizkallah, J. J. Miles, E. Gostick et al., Germ linegoverned recognition of a cancer epitope by an immunodominant human T-cell receptor, J Biol Chem, vol.284, pp.27281-27290, 2009.

C. Xu, N. Ranjbar, M. R. Wu, Z. Dicarlo, J. Wang et al., Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller, BMC Genomics, vol.18, p.5, 2017.

S. Mantovani, B. Palermo, S. Garbelli, R. Campanelli, R. Della-cuna et al., Dominant TCR-alpha requirements for a self antigen recognition in humans, J Immunol, vol.169, pp.6253-260, 2002.
DOI : 10.4049/jimmunol.169.11.6253
URL : http://www.jimmunol.org/content/jimmunol/169/11/6253.full.pdf

J. Dyson, T-cell receptors: tugging on the anchor for a tighter hold on the tumor-associated peptide, Eur J Immunol, vol.45, pp.380-382, 2015.

F. Madura, P. J. Rizkallah, C. J. Holland, A. Fuller, A. Bulek et al., Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides, Eur J Immunol, vol.45, pp.584-91, 2015.
DOI : 10.1002/eji.201445114
URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201445114/pdf

A. Bovay, V. Zoete, G. Dolton, A. M. Bulek, D. K. Cole et al., T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus, Eur J Immunol, vol.48, pp.258-72, 2018.

D. N. Garboczi, P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison et al., Structure of the complex between human T-cell receptor, viral peptide and HLA-A2, Nature, vol.384, pp.134-175, 1996.
DOI : 10.1038/384134a0

V. P. Argaet, C. W. Schmidt, S. R. Burrows, S. L. Silins, M. G. Kurilla et al., Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus, J Exp Med, vol.180, pp.2335-2375, 1994.

M. G. Mcheyzer-williams and M. M. Davis, Antigen-specific development of primary and memory T cells in vivo, Science, vol.268, pp.106-117, 1995.